Our Companies

AXIM Biotechnologies

CANCHEW®

This first in the world, patented cannabinoid-based gum is derived from high-CBD hemp oil. Manufactured in the U.S. and legal in all 50 states, sugar-free mint flavored CanChew® gum is an efficient and reliable method of absorbing CBD hemp oil as a dietary supplement. Each piece of CanChew® contains 50 mg of hemp oil and 10 mg of CBD.

MEDCHEW® RX

AXIM Biotech is currently in clinical trials for their combined CBD and THC delayed-release gum, MedChew® RX, for the pain and spasticity associated with multiple sclerosis. Once approved by the European Medicines Agency (EMA), the gum will be offered across the European Union.

ORIMAX™

AXIM Biotechnologies’ patent-pending dental hygiene line, based on Cannabigerol (CBG), will target both daily use oral care and the resolution of oral infections and gum disease. AXIM has selected CBG for its suggested anti-inflammatory and antibacterial properties to protect against the daily trauma caused to the mouth through chewing, speaking, and buildup of infectious organisms.

ReneCann™

AXIM’s hemp oil derived rejuvenating skin care line, Renecann™ cannabinoid based hair and skin products will be developed for the discerning daily use customer. Capitalizing on the cannabinoids, essential amino acids, and vitamins and minerals available in hemp oil, the line will contain products like anti-aging cream, lip balm, diaper rash cream, and anti-acne lotion.

AX-1602

AX-1602 is AXIM Biotechnologies’ patent-pending topical ointment for psoriasis and eczema, formulated with cannabigerol (CBG) and other cannabinoids. AXIM’s CBG ointment will be tested in a placebo controlled study to best judge its efficacy before moving into phase I trials.